TrialVaccine2021

Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees.

Eugene V Millar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.